Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers

被引:0
|
作者
Muddu, V. [1 ]
Shah, A. [2 ]
Raj, A. [3 ]
Bahl, A. [4 ]
Thirumalairaj, R. [5 ]
Ghosh, J. [6 ]
Ostwal, V. [2 ]
Rajappa, S. [7 ]
Vora, A. [8 ]
Lavingia, V. [9 ]
Sharma, A. [10 ]
Khan, A. [1 ]
Rohatgi, N. [4 ]
Mahajan, M. [11 ]
Chandrakanth, M. [6 ]
Ramaswamy, A. [12 ]
机构
[1] AIG Hosp, Hyderabad, India
[2] Tata Mem Hosp, Tata Mem Ctr, Mumbai, Maharashtra, India
[3] Sarvodaya Hosp, Faridabad, India
[4] Fortis Canc Inst, Gurgaon, India
[5] Apollo Canc Ctr, Chennai, Tamil Nadu, India
[6] Tata Med Ctr, Kolkata, India
[7] Basavatarakam Indo Amer Canc Hosp, Hyderabad, India
[8] HOPE Oncol Care Clin, New Delhi, India
[9] HCG Canc Ctr, Ahmadabad, Gujarat, India
[10] All India Inst Med Sci, New Delhi, India
[11] Pacific Med Coll Hosp, Udaipur, Rajasthan, India
[12] Tata Mem Hosp, Mumbai, Maharashtra, India
关键词
D O I
10.1016/j.annonc.2023.04.265
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P-209
引用
收藏
页码:S90 / S90
页数:1
相关论文
共 50 条
  • [21] Second-line Chemotherapy Prolongs Survival in Real World Patients With Advanced Biliary Tract and Gallbladder Cancers A Multicenter Retrospective Population-based Cohort Study
    Zaidi, Adnan
    Chandna, Nicholas
    Narasimhan, Gopinath
    Moser, Michael
    Haider, Kamal
    Chalchal, Haji
    Shaw, John
    Ahmed, Shahid
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (03): : 93 - 98
  • [22] Systemic chemotherapy for advanced biliary tract cancers: present and future
    Malka, D.
    Boige, V.
    Ducreux, M.
    ONCOLOGIE, 2010, 12 (10) : 623 - 628
  • [23] Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
    Verderame, F.
    Russo, A.
    Di Leo, R.
    Badalamenti, G.
    Santangelo, D.
    Cicero, G.
    Valerio, M. R.
    Gulotta, G.
    Tomasello, G.
    Gebbia, N.
    Fulfaro, F.
    ANNALS OF ONCOLOGY, 2006, 17 : VII68 - VII72
  • [24] Anti-PD-1 therapy combined with chemotherapy or target therapy in patients with advanced biliary tract cancer in real-world clinical setting
    Sun, D.
    Ma, J.
    Han, C.
    Wang, J.
    Qian, Y.
    Chen, G.
    Li, X.
    Zhang, J.
    Song, J.
    Zhao, X.
    Cai, S.
    Hu, Y.
    ANNALS OF ONCOLOGY, 2018, 29 : 437 - 437
  • [25] Real-world treatments and outcomes of resected biliary tract cancers in British Columbia, Canada.
    Boutin, Melina
    Safro, Maria
    Yang, Jenny
    Jafari, Helia
    Davies, Janine Marie
    Gill, Sharlene
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 505 - 505
  • [26] Durvalumab: A Review in Advanced Biliary Tract Cancer
    Fung, Simon
    Syed, Yahiya Y.
    TARGETED ONCOLOGY, 2023, 18 (06) : 965 - 972
  • [27] Durvalumab: A Review in Advanced Biliary Tract Cancer
    Simon Fung
    Yahiya Y. Syed
    Targeted Oncology, 2023, 18 : 965 - 972
  • [28] Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis
    Cheon, Jaekyung
    Lee, Choong-kun
    Sang, Yun Beom
    Choi, Hye Jin
    Kim, Min Hwan
    Ji, Jun Ho
    Ko, Kwang Hyun
    Kwon, Chang-Il
    Kim, Dae Jung
    Choi, Sung Hoon
    Kim, Chan
    Kang, Beodeul
    Chon, Hong Jae
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [29] Plain language summary of the TOPAZ-1 study: durvalumab and chemotherapy for advanced biliary tract cancer
    Oh, Do-Youn
    He, Aiwu Ruth
    Qin, Shukui
    Chen, Li-Tzong
    Okusaka, Takuji
    Vogel, Arndt
    Kim, Jin Won
    Suksombooncharoen, Thatthan
    Lee, Myung Ah
    Kitano, Masayuki
    Burris, Howard
    Bouattour, Mohamed
    Tanasanvimon, Suebpong
    McNamara, Mairead G.
    Zaucha, Renata
    Avallone, Antonio
    Tan, Benjamin
    Cundom, Juan
    Lee, Choong-kun
    Takahashi, Hidenori
    Ikeda, Masafumi
    Chen, Jen-Shi
    Wang, Julie
    Makowsky, Mallory
    Rokutanda, Nana
    Zotkiewicz, Magdalena
    Kurland, John F.
    Cohen, Gordon
    Valle, Juan W.
    FUTURE ONCOLOGY, 2023, 19 (34) : 2277 - 2289
  • [30] Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab
    LeClair, Jessica N.
    Merl, Man Yee
    Cohenuram, Michael
    Luon, Darren
    CLINICAL LUNG CANCER, 2022, 23 (01) : 34 - 42